Tri-LayoTM Topical Formulations

Tri-Layo™ 3:3 Topical

CBD Concentration
3.000000
CBC Concentration
0.000000
Dry Cannabis
2.500000
Formulation
Balanced THC:CBD
Product Type
Topical
NAFTA Document Indicator
No
Textile Indicator
No
FCC Document Indicator
No
Sender Is Producer Indicator
No

Tri-Layo™ 3:3 Topical

Balanced THC:CBD
Total THC 3 mg/g | Total CBD 3 mg/g
Ingredients

Ingredients: Topical cream (Aloe Barbadensis Leaf Juice, Cyclopentasiloxane, Disodium EDTA, Emulsifying Wax NF, Ethylhexylglycerin, Ethylhexyl Stearate, Phenoxyethanol, Sorbitol, Tocopheryl Acetate, Water), Olive Oil, Cannabis Extract, Citrus Sinensis (Orange) Peel Oil, Lavandula Angustifolia (Lavender) Flower Oil, Mentha Piperita (Peppermint) Leaf Oil

Ingrédients : crème topique (jus de feuilles d’aloe vera, cyclopentasiloxane, EDTA de disodium, cire émulsifiante NF, éthylhexylglycérine, stéarate d’éthylhexyle, phénoxyéthanol, sorbitol, acétate de vitamine E, eau), huile d’olive, extrait de cannabis, Huile de zeste de Citrus Sinensis (oranger doux), huile de fleur de Lavandula Angustifolia (lavande), huile de feuille de Mentha Piperita (menthe poivrée)

THC Concentration
3
CBD Concentration
3
CA$49.99
/ 50g

*Taxes and shipping cost will be calculated at checkout

THC Molecule

What is THC?

THC directly binds to cannabinoid (CB₁ and CB₂) receptors. It is the cannabinoid that may provide benefits for pain, sleep, muscle spasms, nausea and stimulating appetite and is also responsible for the ‘intoxicating’ feeling that some people feel when they absorb cannabinoids. The amount of THC in the cannabis plant varies from less than 1% to as high as 30%. ¹

What is CBD?

CBD indirectly binds to cannabinoid (CB₁ and CB₂) receptors. It does not cause the intoxicating effects that THC does. The effects of CBD include helping to reduce inflammation (anti- inflammatory), lowering pain, helping for nausea and vomiting, reducing anxiety and lowering seizures in people with epilepsy. ¹

Is this product right for me?

It is important to work with your healthcare practitioner as you begin cannabinoid therapy. Your healthcare practitioner will first assess the possible risks and benefits with cannabinoid therapy to determine if this is the right strategy for you.

 

Reference

1. Health Canada. Information for Health Care Professionals: Cannabis (marihuana, marijuana) and the cannabinoids. aem. https://www.canada.ca/en/health-canada/services/drugs-medication/cannabis/information-medical-practitioners/information-health-care-professionals-cannabis-cannabinoids.html